# Dan Roark

> Dan Roark is a Spokane-based engineer, biochemist, serial entrepreneur, angel investor, and CEO of Gestalt Diagnostics. After building laboratory-automation businesses that were acquired by Packard BioScience and Brooks Automation, he turned to digital pathology, where Gestalt's PathFlow platform connects case data, whole-slide images, collaboration tools, and AI inside a vendor-neutral workflow.

- **Role:** Chief Executive Officer and Founder at Gestalt Diagnostics
- **Organizations:** Gestalt Diagnostics, Matrical Bioscience, Brooks Automation, CCS Instruments, Packard BioScience, PerkinElmer, Tecan Group
- **Nationality:** American
- **Education:** B.S. in Biochemistry, Whitworth University, B.S. in Chemical Engineering, Washington State University
- **Known for:** Founded and led multiple life-science technology companies through acquisitions., Contributed to laboratory automation used in work connected with the Human Genome Project., Co-inventor on digital pathology interface patent filings and granted design patents assigned to Gestalt Diagnostics.

## Career timeline

- **1988-1994** — Held a sales leadership role at Tecan, working on laboratory product development, applications, and commercialization.
- **1994-1998** — Co-founded and served as a vice president at CCS Instruments.
- **1998-2002** — After CCS was acquired by Packard BioScience and integrated into PerkinElmer, served in vice president and general manager roles.
- **2002-2013** — Founded and led Matrical Bioscience, a life-science automation company, as CEO.
- **2013-2016** — Following Brooks Automation's acquisition of Matrical, led business development and strategic growth work at Brooks.
- **2017-present** — Leads Gestalt Diagnostics, developing the PathFlow digital pathology platform.
- **2025** — Gestalt completed a $7.5 million Series A financing to expand adoption, AI capabilities, and work toward FDA clearance.
- **2026** — Named to the Spokane Journal of Business 2026 People of Influence list.

## Achievements

- Founded and led multiple life-science technology companies through acquisitions.
- Contributed to laboratory automation used in work connected with the Human Genome Project.
- Co-inventor on digital pathology interface patent filings and granted design patents assigned to Gestalt Diagnostics.
- Led Gestalt Diagnostics through a $7.5 million Series A financing in 2025.
- Named a 2026 Person of Influence by the Spokane Journal of Business.
- Active angel investor, startup mentor, and speaker at entrepreneurial events.

## Latest updates

- **2026-02** — A Gestalt-assigned animated graphical user-interface design patent listing Roark as a co-inventor was granted.
- **2026-01** — Featured as one of the Spokane Journal of Business 2026 People of Influence.
- **2026-01** — Appeared on the GSD Venture Studios podcast to discuss digitizing pathology and commercializing medical AI.
- **2025-07** — Discussed pathology's digital transition in a Spokane Public Radio program on the Inland Northwest medical industry.
- **2025-04** — Gestalt announced a $7.5 million Series A financing.

## Links

- Website: https://gestaltdiagnostics.com/team/danroark/
- LinkedIn: https://www.linkedin.com/in/dan-roark-665723

---

Profile page: https://yespress.io/dan-roark
Published by YesPress — https://yespress.io
Last updated: 2026-08-27